SPONSOR
Ontario Clinical Oncology Group (OCOG)
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Refractory Multiple Myeloma
Ontario Clinical Oncology Group (OCOG) is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Refractory Multiple Myeloma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ontario Clinical Oncology Group (OCOG)
How many clinical trials has Ontario Clinical Oncology Group (OCOG) sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Ontario Clinical Oncology Group (OCOG), of which 1 are actively recruiting participants. These trials cover conditions including Refractory Multiple Myeloma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ontario Clinical Oncology Group (OCOG) research focus on?
Ontario Clinical Oncology Group (OCOG) clinical trials span Refractory Multiple Myeloma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ontario Clinical Oncology Group (OCOG) clinical trial?
To participate in a Ontario Clinical Oncology Group (OCOG) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ontario Clinical Oncology Group (OCOG) trials with current recruitment status updated daily.
Clinical Trials by Ontario Clinical Oncology Group (OCOG)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology